Company intelligence / Profile preview

Beijing Hope Pharmaceutical

Ownership: Private
Development stage: Commercial

Overview

Beijing Hope Pharmaceutical has over two decades of experience in chemical drug R&D and manufacturing. It has completed more than 140 technology transfers to client companies worldwide and obtained over 90 registration approvals for its products. The company holds more than 70 patents across its subsidiaries. Its products cover a wide range of therapeutic areas including oncology, CNS disorders, cardiovascular/cerebrovascular diseases, digestive and respiratory conditions.

Therapeutic areas: OncologyPulmonologyPsychiatryGastroenterologyCardiovascularNeurology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

2 assets

ibrutinib

Commercial

Indications: Oncology

1 more asset in the full pipeline.

Request access →

Partnerships

Reports good cooperative relations with leading pharmaceutical companies domestically and abroad (specific partners not disclosed)

Beyond the preview

Go deeper on Beijing Hope Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Hope Pharmaceutical.

Explore the full profile